SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-185970
Filing Date
2019-06-28
Accepted
2019-06-28 16:02:03
Documents
4
Period of Report
2019-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d766592d8k.htm 8-K 49414
2 EX-10.1 d766592dex101.htm EX-10.1 77161
3 EX-10.2 d766592dex102.htm EX-10.2 8540
4 EX-10.3 d766592dex103.htm EX-10.3 77795
  Complete submission text file 0001193125-19-185970.txt   214410
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 19929205
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10